Dopaminergic neuron cell replacement

Dopaminergic neuron cell replacement is a regenerative medicine strategy aimed at restoring striatal dopaminergic innervation in the brains of patients with Parkinson’s disease and related neurodegenerative disorders[1][2][3][4][5][6][7]. This approach involves transplanting dopaminergic neurons, typically derived from human embryonic stem cells or induced pluripotent stem cells, into specific brain regions such as the putamen. The goal is to replenish lost dopamine-producing cells and improve motor and other neurological functions by reconstituting the damaged nigrostriatal pathway. Clinical trials focus on ensuring safety and efficacy, with biomarkers like [^18^F]-DOPA PET imaging used to monitor graft survival and function. Major safety and therapeutic challenges include immune rejection, surgical risks, tumor formation, and the variable integration and function of the grafted cells. Cell replacement is not a single molecular entity but rather a cell-based regenerative therapy.

Other names

Dopaminergic cellDA neuronmidbrain dopaminergic neuronstriatal dopaminergic neuron

Cell therapy restores lost dopaminergic function in the brain by integrating transplanted neurons derived from pluripotent stem cells or other sources, which secrete dopamine and re-establish neural circuits[1][2][3][5][7].